Masaru Ubasawa
Mitsubishi Chemical Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Masaru Ubasawa.
Antimicrobial Agents and Chemotherapy | 1990
Masanori Baba; E. De Clercq; S Iida; H Tanaka; Issei Nitta; Masaru Ubasawa; H Takashima; K Sekiya; K Umezu; Hiroshi Nakashima
The novel 6-substituted acyclouridine derivatives 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT), 1-[(2-hydroxyethoxy)methyl]-6-(3-methylphenylthio)thymine (HEPT-M), 6-cyclohexylthio-1-[(2-hydroxyethoxy) methyl]thymine (HEPT-H), and 1-[(2-hydroxyethoxy)methyl]-6-phenylthio-2- thiothymine (HEPT-S) have proved to be potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) replication in a variety of cell systems, including peripheral blood lymphocytes. They are not inhibitory to the replication of HIV-2. HEPT-S emerged as the most active congener, with a 50% inhibitory concentration of 1.6 microM for HIV-1 (human T-cell lymphotropic virus type IIIB) in MT-4 cells. We also examined the pharmacokinetics of the compounds following oral administration to rats. The pharmacokinetic profile varied considerably from one compound to another. The highest concentration in plasma (7.4 micrograms/ml, or 22.8 microM) was achieved by HEPT-S within 30 min after administration of an oral dose of 20 mg/kg of body weight. HEPT-S can be considered a promising candidate for the treatment of HIV-1 infections.
European Journal of Medicinal Chemistry | 1996
E. De Clercq; H Takashima; Masaru Ubasawa; K Sekiya; Masanori Baba; H Walther
Summary The dioxypyrimidine ring of 5,6-substituted 1-[(2-hydroxyethoxy)methyl]uracils is an extended ‘partial π system’ with ring distortion. PM3-MM+ geometry optimization suggested a lipophilic ‘butterfly-like’ orientation which was also found in other non-nucleoside inhibitors that interact with the HIV-1 reverse transcriptase. Multivariate QSAR has shown that discrimination between the antiviral response and undesired cytotoxicity is possible. Related to the C-6 thiophenyl ring substituents and to modifications at the C-5 position, the antiviral response depends on hydrogen-bonding forces, steric parameters, and electronic properties. The cytotoxicity depends on the lipophilicity and steric parameters.
Nucleosides, Nucleotides & Nucleic Acids | 1998
Masaru Ubasawa; Hideaki Takashima; Kouichi Sdciya
Abstract An acyclonucleoside synthesis was investigated on the regioselective introduction of an acyclochain. We found that iodotrimethylsilane catalyzed the reaction of acyclochain introduction as well as its migration from S2 to N1 of 2-thiothymine and from N7 to N9 position of guanine. By taking the findings into account, several acyclo-nucleosides were synthesized in a simple one-pot procedure.
Proceedings of the National Academy of Sciences of the United States of America | 1991
Masanori Baba; E. De Clercq; H Tanaka; Masaru Ubasawa; H Takashima; K Sekiya; Issei Nitta; K Umezu; Hiroshi Nakashima; Shuichi Mori
Antimicrobial Agents and Chemotherapy | 1994
Masanori Baba; S Shigeta; Satoshi Yuasa; H Takashima; K Sekiya; Masaru Ubasawa; H Tanaka; Tadashi Miyasaka; R. T. Walker; E. De Clercq
Archive | 1994
Hideaki Takashima; Naoko Inoue; Masaru Ubasawa; Kouichi Sekiya; Shingo Yabuuchi
Journal of Medicinal Chemistry | 1991
H Tanaka; Masanori Baba; S. Saito; Tadashi Miyasaka; H Takashima; K Sekiya; Masaru Ubasawa; Issei Nitta; R. T. Walker; Hiroshi Nakashima; E. De Clercq
Archive | 1997
Masaru Ubasawa; Kouichi Sekiya; Hideaki Takashima; Naoko Ueda; Satoshi Yuasa; Naohiro Kamiya
Molecular Pharmacology | 1991
Masanori Baba; E. De Clercq; H Tanaka; Masaru Ubasawa; H Takashima; K Sekiya; Issei Nitta; K Umezu; R. T. Walker; Shuichi Mori; Masahiko Ito; S Shigeta; Tadashi Miyasaka
Molecular Pharmacology | 1993
S Yuasa; Y Sadakata; H Takashima; K Sekiya; N Inouye; Masaru Ubasawa; Masanori Baba